BPC
RDY icon

Banque Pictet & Cie’s Dr. Reddy's Laboratories RDY Stock Holding History

Banque Pictet & Cie’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-75,000
Closed -$624K – 371
2017
Q2 		$624K Buy
+75,000
New +$610K 0.01% 279

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Banque Pictet & Cie's RDY Position: Q3 2017 in Review

Banque Pictet & Cie sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 75,000 shares — an estimated $624K sold.

Banque Pictet & Cie first reported a position in RDY in Q2 2017 and held it in 1 quarter. The position peaked at $624K in Q2 2017. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

  • Banque Pictet & Cie reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
  • Banque Pictet & Cie sold 75,000 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $624K.
  • Banque Pictet & Cie first reported a position in Dr. Reddy's Laboratories in Q2 2017 and held it in 1 quarter.
  • Banque Pictet & Cie's Dr. Reddy's Laboratories position peaked at $624K in Q2 2017.
  • 118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on Banque Pictet & Cie's 13F filing for Q3 2017, filed 7 Nov 2017.